Distinct sleep disturbance and cognitive dysfunction profiles in oncology outpatients receiving chemotherapy
- PMID: 36066629
- DOI: 10.1007/s00520-022-07350-6
Distinct sleep disturbance and cognitive dysfunction profiles in oncology outpatients receiving chemotherapy
Abstract
Purpose: Sleep disturbance and cancer-related cognitive impairment (CRCI) are two of the most common symptoms reported by patients undergoing chemotherapy. Less is known about how these symptoms co-occur and their associated risk factors. Study purposes were to identify subgroups of patients with distinct sleep disturbance and CRCI profiles and evaluate for differences among the subgroups in demographic and clinical characteristics, symptom severity scores, and QOL outcomes.
Methods: A total of 1,333 oncology outpatients receiving chemotherapy completed self-report questionnaires on sleep disturbance and cognitive dysfunction six times over two cycles of chemotherapy. Latent profile analysis was used to identify distinct sleep disturbance AND cognitive dysfunction profiles. Parametric and non-parametric tests were used to evaluate for differences among the classes.
Results: Two distinct profiles were identified (i.e., Low = low levels of both sleep disturbance and cognitive dysfunction (53.5%); High = high levels of both sleep disturbance and cognitive dysfunction (45.5%)). Patients in the High class were younger, more likely to be female, had a lower functional status and a higher level of comorbidity. In addition, these patients had a higher symptom burden and a lower quality of life.
Conclusion: Almost half of the patients undergoing chemotherapy experienced clinically meaningful levels of both symptoms. Of note, sleep disturbance is frequently overlooked by both clinicians and patients. Clinicians need to recommend cognitive rehabilitation and physical activity programs to decrease patients' symptom burden.
Keywords: Cancer; Chemotherapy; Cognitive impairment; Depression; Fatigue; Insomnia; Pain; Quality of life; Sleep disturbance.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Impact of worst pain severity and morning fatigue profiles on oncology outpatients' symptom burden and quality of life.Support Care Cancer. 2022 Dec;30(12):9929-9944. doi: 10.1007/s00520-022-07431-6. Epub 2022 Nov 10. Support Care Cancer. 2022. PMID: 36355215
-
Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes.Sleep Med. 2022 Jul;95:91-104. doi: 10.1016/j.sleep.2022.04.023. Epub 2022 May 2. Sleep Med. 2022. PMID: 35569331
-
Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.Sleep. 2019 Oct 9;42(10):zsz151. doi: 10.1093/sleep/zsz151. Sleep. 2019. PMID: 31361899 Free PMC article.
-
Worst Pain Severity Profiles of Oncology Patients Are Associated With Significant Stress and Multiple Co-Occurring Symptoms.J Pain. 2022 Jan;23(1):74-88. doi: 10.1016/j.jpain.2021.07.001. Epub 2021 Jul 21. J Pain. 2022. PMID: 34298161 Free PMC article.
-
Distinct Wound Healing and Quality-of-Life Outcomes in Subgroups of Patients With Venous Leg Ulcers With Different Symptom Cluster Experiences.J Pain Symptom Manage. 2017 May;53(5):871-879. doi: 10.1016/j.jpainsymman.2016.12.336. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063868 Review.
Cited by
-
Risk Factors for Negative Emotions in Patients Undergoing Radical Resection of Hilar Cholangiocarcinoma and Their Influence on Prognosis.Int J Gen Med. 2023 Dec 11;16:5841-5853. doi: 10.2147/IJGM.S440469. eCollection 2023. Int J Gen Med. 2023. PMID: 38106978 Free PMC article.
-
Visual analysis of the research frontiers, hotspots and trends of exercise therapy intervention in tumor-related sleep-wake disorders.Front Oncol. 2024 Apr 29;14:1392844. doi: 10.3389/fonc.2024.1392844. eCollection 2024. Front Oncol. 2024. PMID: 38741781 Free PMC article.
-
A proposed multi-domain, digital model for capturing functional status and health-related quality of life in oncology.Clin Transl Sci. 2024 Jan;17(1):e13712. doi: 10.1111/cts.13712. Clin Transl Sci. 2024. PMID: 38266055 Free PMC article. Review.
-
Comparing the sensitivity of fatigue and sleep disturbance assessment tools in women with advanced cancer undergoing chemotherapy.Asia Pac J Oncol Nurs. 2023 Oct 31;11(2):100331. doi: 10.1016/j.apjon.2023.100331. eCollection 2024 Feb. Asia Pac J Oncol Nurs. 2023. PMID: 38283667 Free PMC article.
References
-
- Atallah M, Cooper B, Munoz RF, Paul SM, Anguera J, Levine JD, Hammer M, Wright F, Chen LM, Melisko M, Conley YP, Miaskowski C, Dunn LB (2020) Psychological symptoms and stress are associated with decrements in attentional function in cancer patients undergoing chemotherapy. Cancer Nurs 43:402–410 - PubMed - DOI
-
- Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT: the alcohol use disorders identification test: guidelines for use in primary care. World Health Organization, Geneva, Switzerland
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical